A biorepository for cancer research and precision medicine
The Caris Biorepository Research Protocol
This study is collecting and storing samples from cancer patients to help researchers find better treatments and improve care for people with cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Caris Science, Inc. Industry-sponsored |
| Locations | 38 sites (Mobile, Alabama and 37 other locations) |
| Trial ID | NCT01499394 on ClinicalTrials.gov |
What this trial studies
The Caris Biorepository collects and stores biological specimens and clinical data to support research aimed at advancing precision medicine in cancer care. This observational project aims to provide researchers and healthcare professionals with access to high-quality human specimens and associated data, facilitating the correlation of clinical outcomes with biospecimen information. By maintaining the integrity and relevance of these specimens, the biorepository seeks to enhance drug development, clinical trials, and healthcare policies. The initiative fosters collaboration among various entities, including government, academia, and industry, to improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who can provide informed consent.
Not a fit: Patients who are prisoners or minors, as well as those unable to give informed consent, will not benefit from this study.
Why it matters
Potential benefit: If successful, this biorepository could significantly enhance the understanding of cancer treatments and improve personalized care for patients.
How similar studies have performed: Other biorepositories have shown success in advancing cancer research and precision medicine, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Capacity to provide informed consent Exclusion Criteria: * Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository. * Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults. * Individuals who lack the capacity to give informed consent
Where this trial is running
Mobile, Alabama and 37 other locations
- University of South Alabama — Mobile, Alabama, United States (Recruiting)
- Southwest Medical Imaging — Scottsdale, Arizona, United States (Recruiting)
- St. Bernards Medical Center — Jonesboro, Arkansas, United States (Recruiting)
- CARTI Cancer Center — Little Rock, Arkansas, United States (Recruiting)
- ObjectiveHealth - ARcare Center for Clinical Research — Little Rock, Arkansas, United States (Recruiting)
- Lee Memorial Health System — Fort Myers, Florida, United States (Recruiting)
- Cancer Care of North Florida — Lake City, Florida, United States (Recruiting)
- Advent Health — Orlando, Florida, United States (Recruiting)
- The University of South Florida — Tampa, Florida, United States (Recruiting)
- Cleveland Clinic Florida — Weston, Florida, United States (Recruiting)
- Phoebe Putney Memorial Hospital — Albany, Georgia, United States (Recruiting)
- Emory University — Atlanta, Georgia, United States (Recruiting)
- Augusta University Research Institute — Augusta, Georgia, United States (Recruiting)
- Cancer Center of Middle Georgia — Dublin, Georgia, United States (Recruiting)
- Hope and Healing Cancer Services — Hinsdale, Illinois, United States (Recruiting)
- CHRISTUS - St. Frances Cabrini Hospital — Alexandria, Louisiana, United States (Recruiting)
- Tulane University — New Orleans, Louisiana, United States (Recruiting)
- CHRISTUS - Highland Medical Center — Shreveport, Louisiana, United States (Recruiting)
- Mercy Medical Center — Baltimore, Maryland, United States (Recruiting)
- Sinai Hospital of Baltimore — Baltimore, Maryland, United States (Recruiting)
- Hattiesburg Clinic — Hattiesburg, Mississippi, United States (Recruiting)
- Jackson Oncology Associates — Jackson, Mississippi, United States (Recruiting)
- University of Mississippi Medical Center — Jackson, Mississippi, United States (Recruiting)
- ObjectiveHealth - Premier Health Research — Sparta, New Jersey, United States (Recruiting)
- CHRISTUS - St. Vincent Regional Cancer Center — Santa Fe, New Mexico, United States (Recruiting)
- St. Lawrence Health System — Potsdam, New York, United States (Recruiting)
- National Translational Research Group — Ridge, New York, United States (Recruiting)
- Altru Health System — Grand Forks, North Dakota, United States (Recruiting)
- NEO Urology Associates — Boardman, Ohio, United States (Recruiting)
- Great Lakes Medical Research — Cleveland, Ohio, United States (Recruiting)
- Bend Memorial Clinic — Bend, Oregon, United States (Recruiting)
- Clinical Biotechnology Research Institute at RSFH — Charleston, South Carolina, United States (Recruiting)
- Spartanburg Regional Health Services — Spartanburg, South Carolina, United States (Recruiting)
- West Cancer Center — Germantown, Tennessee, United States (Recruiting)
- ObjectiveHealth - Amarillo Premier Research — Amarillo, Texas, United States (Recruiting)
- CHRISTUS - St. Michael's Health — Texarkana, Texas, United States (Recruiting)
- CAMC Clinical Trials — Charleston, West Virginia, United States (Recruiting)
- Mercy Health — Janesville, Wisconsin, United States (Recruiting)
Study contacts
- Principal investigator: Matthew Oberley, MD — Caris Life Sciences
- Study coordinator: Mary Baker
- Email: carisresearch@carisls.com
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.